CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery

Cites (301)

Items 201–299 of 299

1. Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies
   Tao Wang, Jaydev R. Upponi, Vladimir P. Torchilin · 2011 · International Journal of Pharmaceutics
2. 3D printing of multifunctional nanocomposites
   Thomas A. Campbell, О. С. Иванова · 2013 · Nano Today
3. Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool
   Jeffry D. Sander, P. Zaback, J. Keith Joung, Daniel F. Voytas, Drena L Dobbs · 2007 · Nucleic Acids Research
4. Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes
   Crispo, M., Mulet, A. P., Tesson, L., Barrera, N., Cuadro, F., dos Santos-Neto, P. C., Nguyen, T. H., Crénéguy, A., Brusselle, L., Anegón, I. et al. · 2015 · PLOS ONE
5. Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
   Yeh‐Hsing Lao, Kyle K.L. Phua, Kam W. Leong · 2015 · ACS Nano
6. Heritable Gene Knockout in Caenorhabditis elegans by Direct Injection of Cas9–sgRNA Ribonucleoproteins
   Seung Woo Cho, Ji‐Hyun Lee, Dana Carroll, Jin‐Soo Kim, Junho Lee · 2013 · Genetics
7. Therapeutic RNA aptamers in clinical trials
   Padma Sundaram, Helena Kurniawan, Mark Edward Byrne, Jacek Wower · 2012 · European Journal of Pharmaceutical Sciences
8. Cas9-mediated targeting of viral RNA in eukaryotic cells
   Aryn A. Price, Timothy Robert Sampson, Hannah K. Ratner, Arash Grakoui, David S. Weiss · 2015 · Proceedings of the National Academy of Sciences
9. Basis of Pulmonary Toxicity Associated with Cationic Lipid-Mediated Gene Transfer to the Mammalian Lung
   Ronald K. Scheule, Judith A. St. George, Rebecca G. Bagley, John Marshall, Johanne M Kaplan, Geoffrey Y. Akita, Kathryn X. Wang, Edward R. Lee, David J. Harris, Canwen Jiang et al. · 1997 · Human Gene Therapy
10. Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines
    Pollard, Charlotte, Rejman, Joanna, De Haes, Winni, Verrier, Bernard, Van Gulck, Ellen, Naessens, Thomas, De Smedt, Stefaan, Bogaert, Pieter, Grooten, Johan, Vanham, Guido et al. · 2013 · Molecular Therapy
11. Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells
    Wu, Yuxuan, Zhou, Hai, Fan, Xiaoying, Zhang, Ying, Zhang, Man, Wang, Yinghua, Xie, Zhenfei, Bai, Meizhu, Yin, Qi, Liang, Dan et al. · 2015 · Cell Research
12. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
    Chunsheng Dong, Liang Qu, Haoyi Wang, Lin Wei, Yuansu Dong, Sidong Xiong · 2015 · Antiviral Research
13. A ligation-independent cloning technique for high-throughput assembly of transcription activator–like effector genes
    Jonathan Leo Schmid-Burgk, Tobias Schmidt, Vera Kaiser, Klara Höning, Veit Hornung · 2012 · Nature Biotechnology
14. Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice
    Li, Ling, Song, Linjiang, Liu, Xiaowei, Yang, Xi, Li, Xia, He, Tao, Wang, Ning, Yang, Suleixin, Yu, Chuan, Yin, Tao et al. · 2017 · ACS Nano
15. Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9
    Chen, Yongchang, Zheng, Yinghui, Kang, Yu, Yang, Weili, Niu, Yuyu, Guo, Xiangyu, Tu, Zhuchi, Si, Chenyang, Wang, Hong, Xing, Ruxiao et al. · 2015 · Human Molecular Genetics
16. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
    Xin Han, Zongbin Liu, Myeong Chan Jo, Kai Zhang, Ying Li, Zihua Zeng, Nan Li, Youli Zu, Lidong Qin · 2015 · Science Advances
17. A novel, disruptive vaccination technology: Self-adjuvanted RNActive ® vaccines
    Kallen, Karl-Josef, Heidenreich, Regina, Schnee, Margit, Petsch, Benjamin, Schlake, Thomas, Thess, Andreas, Baumhof, Patrick, Scheel, Birgit, Koch, Sven D, Fotin-Mleczek, Mariola · 2013 · Human Vaccines & Immunotherapeutics
18. Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells
    Liu, Yuchen, Zeng, Yayue, Liu, Li, Zhuang, Chengle, Fu, Xing, Huang, Weiren, Cai, Zhiming · 2014 · Nature Communications
19. RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection
    Wang, Jianbin, Quake, Stephen R. · 2014 · Proceedings of the National Academy of Sciences
20. A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture
    O'Geen, Henriette, Henry, Isabelle M., Bhakta, Mital S., Meckler, Joshua F., Segal, David J. · 2015 · Nucleic Acids Research
21. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method
    Kogure, Kentaro, Moriguchi, Rumiko, Sasaki, Kentaro, Ueno, Masaharu, Futaki, Shiroh, Harashima, Hideyoshi · 2004 · Journal of Controlled Release
22. Cas9-chromatin binding information enables more accurate CRISPR off-target prediction
    Singh, Ritambhara, Kuscu, Cem, Quinlan, Aaron, Qi, Yanjun, Adli, Mazhar · 2015 · Nucleic Acids Research
23. Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus
    Zhen, S, Hua, L, Liu, Y-H, Gao, L-C, Fu, J, Wan, D-Y, Dong, L-H, Song, H-F, Gao, X · 2015 · Gene Therapy
24. Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study
    Rafal Kaminski, R. Bella, Chaoran Yin, Jessica Otte, Pasquale Ferrante, Howard Eliot Gendelman, H Li, Rosemarie M. Booze, Jennifer Gordon, Wei Hu et al. · 2016 · Gene Therapy
25. Structural Characteristics of Size-Controlled Self-Aggregates of Deoxycholic Acid-Modified Chitosan and Their Application as a DNA Delivery Carrier
    Young Hyo Kim, Se Hoon Gihm, Chong Rae Park, Kuen Yong Lee, Tae‐Woo Kim, Ick Chan Kwon, Hesson Chung, Seo Young Jeong · 2001 · Bioconjugate Chemistry
26. Antisense oligonucleotides: modifications and clinical trials
    Vivek K. Sharma, Raman K. Sharma, Sunil Kumar Singh · 2014 · MedChemComm
27. WGE: a CRISPR database for genome engineering
    Alex Hodgkins, Anna Farne, Sajith Perera, Tiago Grego, D. Parry-Smith, W. Skarnes, V. Iyer · 2015 · Bioinform.
28. Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9
    Anders, Carolin, Bargsten, Katja, Jinek, Martin · 2016 · Molecular Cell
29. Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
    Jennifer L. Gori, Patrick D. Hsu, Morgan L. Maeder, Shen Shen, G. Grant Welstead, David A. Bumcrot · 2015 · Human Gene Therapy
30. A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Specification
    Syandan Chakraborty, HaYeun Ji, Ami M. Kabadi, Charles A. Gersbach, Nicolas Christoforou, Kam W. Leong · 2014 · Stem Cell Reports
31. CRISPRseek: A Bioconductor Package to Identify Target-Specific Guide RNAs for CRISPR-Cas9 Genome-Editing Systems
    Lihua Julie Zhu, Benjamin R. Holmes, Neil Aronin M. D, Michael H. Brodsky · 2014 · PLoS ONE
32. A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9
    Kelli J. Carroll, Catherine A. Makarewich, John McAnally, Douglas M. Anderson, Lorena Zentilin, Ning Liu, Mauro Giacca, Rhonda Bassel‐Duby, Eric N. Olson · 2015 · Proceedings of the National Academy of Sciences
33. Comparative transfection of DNA into primary and transformed mammalian cells from different lineages
    Rosalie Maurisse, David de Semir, Hamid Emamekhoo, Babak Bedayat, Alireza Abdolmohammadi, Hooman Parsi, Dieter C. Gruenert · 2010 · BMC Biotechnology
34. Carbon nanotubes as vectors for gene therapy: Past achievements, present challenges and future goals
    Katie Bates, Kostas Kostarelos · 2013 · Advanced Drug Delivery Reviews
35. Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer
    Warefta Hasan, Kevin S. Chu, Anuradha Gullapalli, Stuart S. Dunn, Elizabeth M. Enlow, J. Christopher Luft, Shaomin Tian, Mary E. Napier, Patrick D. Pohlhaus, Jason P. Rolland et al. · 2011 · Nano Letters
36. Synthetic CRISPR RNA-Cas9–guided genome editing in human cells
    Meghdad Rahdar, Moira A. McMahon, Thazha P. Prakash, Eric E. Swayze, C. Frank Bennett, Don W. Cleveland · 2015 · Proceedings of the National Academy of Sciences
37. megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering
    Sandrine Boissel, Jordan Jarjour, Alexander Astrakhan, Andrew Adey, Agnès Gouble, Philippe N. Duchateau, Jay Shendure, Barry L. Stoddard, Michael T. Certo, David A. Baker et al. · 2013 · Nucleic Acids Research
38. Targeted Gene Correction Minimally Impacts Whole-Genome Mutational Load in Human-Disease-Specific Induced Pluripotent Stem Cell Clones
    Suzuki, Keiichiro, Yu, Chang, Qu, Jing, Li, Mo, Yao, Xiaotian, Yuan, Tingting, Goebl, April, Tang, Senwei, Ren, Ruotong, Aizawa, Emi et al. · 2014 · Cell Stem Cell
39. Reductively Responsive siRNA-Conjugated Hydrogel Nanoparticles for Gene Silencing
    Stuart S. Dunn, Shaomin Tian, Steven Blake, Jin Wang, Ashley L. Galloway, Andrew Murphy, Patrick D. Pohlhaus, Jason P. Rolland, Mary E. Napier, Joseph M. DeSimone · 2012 · Journal of the American Chemical Society
40. Effective gene targeting in rabbits using RNA-guided Cas9 nucleases
    Dongshan Yang, Jie Xu, Tianqing Zhu, Jianglin Fan, Liangxue Lai, Jifeng Zhang, Y. Eugene Chen · 2014 · Journal of Molecular Cell Biology
41. Recent Advances in Nanoparticle-Mediated siRNA Delivery
    John‐Michael Williford, Juan Wu, Yong Ren, Maani M. Archang, Kam W. Leong, Hai‐Quan Mao · 2014 · Annual Review of Biomedical Engineering
42. Chinese scientists to pioneer first human CRISPR trial
    David Cyranoski · 2016 · Nature
43. MicroRNA delivery for regenerative medicine
    Bo Peng, Yongming Chen, Kam W. Leong · 2015 · Advanced Drug Delivery Reviews
44. Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format
    Kyle K.L. Phua, Kam W. Leong, Smita K. Nair · 2013 · Journal of Controlled Release
45. Engineered Viruses as Genome Editing Devices
    Xiaoyu Chen, Manuel A.F.V. Gonçalves · 2015 · Molecular Therapy
46. Structural basis for the altered PAM specificities of engineered CRISPR-cas9
    Hirano, Seiichi, Nishimasu, Hiroshi, Ishitani, Ryuichiro, Nureki, Osamu · 2016 · Molecular Cell
47. [30] Microinjection of tissue culture cells
    Monika Graessmann, Adolf Graessmann · 1983 · Methods in enzymology on CD-ROM/Methods in enzymology
48. GT-Scan: identifying unique genomic targets
    Aidan R. O’Brien, Timothy L. Bailey · 2014 · Bioinformatics
49. Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer
    Nader N Hanna, Patricia Ohana, Fred Meir Konikoff, G.A. Leichtmann, Ayala Hubert, Liat Appelbaum, Yael Kopelman, Abraham Czerniak, Abraham Hochberg · 2012 · Cancer Gene Therapy
50. In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency
    Mahiny, Azita J, Dewerth, Alexander, Mays, Lauren E, Alkhaled, Mohammed, Mothes, Benedikt, Malaeksefat, Emad, Loretz, Brigitta, Rottenberger, Jennifer, Brosch, Darina M, Reautschnig, Philipp et al. · 2015 · Nature Biotechnology
51. Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles
    Fink, T L, Klepcyk, P J, Oette, S M, Gedeon, C R, Hyatt, S L, Kowalczyk, T H, Moen, R C, Cooper, M J · 2006 · Gene Therapy
52. Reductively Labile PRINT Particles for the Delivery of Doxorubicin to HeLa Cells
    Robby A. Petros, Patricia A. Ropp, Joseph M. DeSimone · 2008 · Journal of the American Chemical Society
53. Genome editing at the crossroads of delivery, specificity, and fidelity
    Ignazio Maggio, Manuel A.F.V. Gonçalves · 2015 · Trends in biotechnology
54. mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers
    Joanna Rejman, Geertrui Tavernier, Neda Bavarsad, Joseph Demeester, Stefaan C. De Smedt · 2010 · Journal of Controlled Release
55. Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells
    Luhan Yang, Dennis Grishin, Gang Wang, John Aach, Cheng‐Zhong Zhang, Raj Chari, Jason G. Homsy, Xuyu Cai, Yue Zhao, Jian‐Bing Fan et al. · 2014 · Nature Communications
56. Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing
    Wujin Sun, Wenyan Ji, Jordan M. Hall, Quanyin Hu, Chao Wang, Chase L. Beisel, Zhen Gu · 2015 · Angewandte Chemie
57. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN
    Ain, Qurrat Ul, Chung, Jee Young, Kim, Yong-Hee · 2015 · Journal of Controlled Release
58. Inhibition of HSV-1 Replication by Gene Editing Strategy
    Roehm, Pamela C., Shekarabi, Masoud, Wollebo, Hassen S., Bellizzi, Anna, He, Lifan, Salkind, Julian, Khalili, Kamel · 2016 · Scientific Reports
59. First-in-man Phase 1 Clinical Trial of Gene Therapy for Advanced Pancreatic Cancer: Safety, Biodistribution, and Preliminary Clinical Findings
    Louis Buscail, Barbara Bournet, Fabienne Vernejoul, Gilles Cambois, Hubert Lulka, Naïma Hanoun, Marlène Dufresne, Aline Meulle, Alix Vignolle‐Vidoni, Lætitia Ligat et al. · 2015 · Molecular Therapy
60. Mutations altering the cleavage specificity of a homing endonuclease
    Lenny M. Seligman · 2002 · Nucleic Acids Research
61. DNA-binding-domain fusions enhance the targeting range and precision of Cas9
    Mehmet Fatih Bolukbasi, Ankit Gupta, Sarah Oikemus, Alan G. Derr, Manuel G. Garber, Michael H Brodsky, Lihua Julie Zhu, Scot A. Wolfe · 2015 · Nature Methods
62. Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases
    Lanjuan Li, Huaying Wang, Zhan Yuin Ong, Kaijin Xu, Pui Lai Rachel Ee, Shusen Zheng, James L. Hedrick, Yi Yan Yang · 2010 · Nano Today
63. Non-viral delivery of genome-editing nucleases for gene therapy
    M Wang, Zachary Glass, Qiaobing Xu · 2016 · Gene Therapy
64. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
    LaFountaine, Justin S., Fathe, Kristin, Smyth, Hugh D.C. · 2015 · International Journal of Pharmaceutics
65. FibromiRs: translating molecular discoveries into new anti-fibrotic drugs
    Nicolas Pottier, Christelle Cauffiez, Michaël Perrais, Pascal Barbry, Bernard P. Mari · 2014 · Trends in Pharmacological Sciences
66. Nested chromosomal fragmentation in yeast using the meganuclease I-SceI: a new method for physical mapping of eukaryotic genomes
    Agnès Thierry, Bernard Dujon · 1992 · Nucleic Acids Research
67. Homing endonuclease I-CreI derivatives with novel DNA target specificities
    Laura E. Rosen, Holly A. Morrison, Selma Masri, Michael J. Brown, Brendan Springstubb, Django R. Sussman, Barry L. Stoddard, Lenny M. Seligman · 2006 · Nucleic Acids Research
68. An RNA-aptamer-based two-color CRISPR labeling system
    Siyuan S. Wang, Jun-Han Su, Feng Zhang, Xiaowei Zhuang · 2016 · Scientific Reports
69. Heritable Multiplex Genetic Engineering in Rats Using CRISPR/Cas9
    Yuanwu Ma, Bin Shen, Xu Zhang, Yingdong Lu, Wei Chen, Jing Ma, Xingxu Huang, Lianfeng Zhang · 2014 · PLoS ONE
70. Chemical Modification of siRNA Bases To Probe and Enhance RNA Interference
    Hayden Peacock, Arunkumar Kannan, Peter A. Beal, Cynthia J. Burrows · 2011 · The Journal of Organic Chemistry
71. Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery
    Chung‐Yin Lin, Han-Yi Hsieh, William George Pitt, Chiung-Yin Huang, I-Chou Tseng, Chih‐Kuang Yeh, Kuo‐Chen Wei, Hao-Li Liu · 2015 · Journal of Controlled Release
72. A Multifunctional Envelope-type Nanodevice for Use in Nanomedicine: Concept and Applications
    Takashi Nakamura, Hidetaka Akita, Yuma Yamada, Hiroto Hatakeyama, Hideyoshi Harashima · 2012 · Accounts of Chemical Research
73. Generation of an ICF Syndrome Model by Efficient Genome Editing of Human Induced Pluripotent Stem Cells Using the CRISPR System
    Horii, Takuro, Tamura, Daiki, Morita, Sumiyo, Kimura, Mika, Hatada, Izuho · 2013 · International Journal of Molecular Sciences
74. The use of cationic microbubbles to improve ultrasound-targeted gene delivery to the ischemic myocardium
    Lu Sun, Chia-Wen Huang, Jun Wu, Ko‐Jie Chen, Shu-Hong Li, Richard D. Weisel, Harry Rakowski, Hsing‐Wen Sung, Ren‐Ke Li · 2012 · Biomaterials
75. Observation of a Rectangular Columnar Phase in a DNA−Calcium−Zwitterionic Lipid Complex
    Jennifer J. McManus, Joachim Oskar Rädler, Kenneth A. Dawson · 2004 · Journal of the American Chemical Society
76. Solid-Phase Chemical Synthesis of Phosphonoacetate and Thiophosphonoacetate Oligodeoxynucleotides
    Douglas J. Dellinger, David M. Sheehan, Nanna K. Christensen, James G. Lindberg, Marvin H. Caruthers · 2003 · Journal of the American Chemical Society
77. Transcutaneous Ultrasound Augments Naked DNA Transfection of Skeletal Muscle
    Peter Schratzberger, Joseph G. Krainin, Gabriele Schratzberger, Marcy Silver, Hong Ma, Marianne Kearney, Robert F. Zuk, Axel F. Brisken, Douglas W. Losordo, Jeffrey M. Isner · 2002 · Molecular Therapy
78. Zinc-finger nucleases: how to play two good hands
    Mark Isalan · 2011 · Nature Methods
79. Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease
    José L. Tlaxca, Joshua J. Rychak, Peter B. Ernst, Prasad R. Konkalmatt, Talent I. Shevchenko, Theresa T. Pizarro, Jesús Rivera–Nieves, Alexander L. Klibanov, Michael Brandeau Lawrence · 2012 · Journal of Controlled Release
80. Tuning Physical Properties of Nanocomplexes through Microfluidics-Assisted Confinement
    Yi‐Ping Ho, Christopher L. Grigsby, Feng Zhao, Kam W. Leong · 2011 · Nano Letters
81. Three-Dimensional Hydrodynamic Focusing Method for Polyplex Synthesis
    Mengqian Lu, Yi‐Ping Ho, Christopher L. Grigsby, Ahmad Nawaz, Kam W. Leong, Tony Jun Huang · 2013 · ACS Nano
82. Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases
    Johnny H. Hu, Kevin M Davis, David R. Liu · 2016 · Cell chemical biology
83. PEGylation Improves Nanoparticle Formation and Transfection Efficiency of Messenger RNA
    Senta Üzgün, Gabriela Nica, Corinna Pfeifer, Michele Bosinco, Kai Michaelis, Jean‐François Lutz, Marc Schneider, Joseph Rosenecker, Carsten Rudolph · 2011 · Pharmaceutical Research
84. RNA Replicon Delivery via Lipid-Complexed PRINT Protein Particles
    Jing Xu, J. Christopher Luft, Xianwen Yi, Shaomin Tian, Gary Owens, Jin Wang, Ashley R. Johnson, Peter Berglund, Jonathan Smith, Mary E. Napier et al. · 2013 · Molecular Pharmaceutics
85. Microfluidic Preparation of Polymer-Nucleic Acid Nanocomplexes Improves Nonviral Gene Transfer
    Christopher L. Grigsby, Yi‐Ping Ho, Chao Lin, Johan F. J. Engbersen, Kam W. Leong · 2013 · Scientific Reports
86. SNS01-T Modulation of eIF5A Inhibits B-cell Cancer Progression and Synergizes With Bortezomib and Lenalidomide
    Sarah M. Francis, Catherine A. Taylor, Terence Tang, Zhongda Liu, Qifa Zheng, Richard S. Dondero, John E. Thompson · 2014 · Molecular Therapy
87. Biomaterials in RNAi therapeutics: quo vadis?
    Ernst Wagner · 2013 · Biomaterials Science
88. CRISPR‐Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering
    Marion Kirchner, Sabine Schneider · 2015 · Angewandte Chemie International Edition
89. Nonviral Vectors
    Tyler J. Goodwin, Leaf Huang · 2014 · Advances in genetics
90. Applications of Cas9 as an RNA‐programmed RNA‐binding protein
    David A. Nelles, Mark Y. Fang, Stefan Aigner, Gene Wei-Ming Yeo · 2015 · BioEssays
91. CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering
    Amrita Singh, Debojyoti Chakraborty, Souvik Maiti · 2016 · Chemical Society Reviews
92. The convergence of quantum-dot-mediated fluorescence resonance energy transfer and microfluidics for monitoring DNA polyplex self-assembly in real time
    Yi‐Ping Ho, Hunter H. Chen, Kam W. Leong, Tza‐Huei Wang · 2009 · Nanotechnology
93. Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes
    Ximing Xu, Ramille M. Capito, Myron Spector · 2007 · Journal of Biomedical Materials Research Part A
94. Microencapsulation of insulin using a W/O/W double emulsion followed by complex coacervation to provide protection in the gastrointestinal tract
    Fernando Cárdenas-Bailón, Guillermo Ismael Osorio-Revilla, Tzayhrí Gallardo‐Velázquez · 2015 · Journal of Microencapsulation
95. Novartis secures first CRISPR pharma collaborations
    Asher Mullard · 2015 · Nature Reviews Drug Discovery
96. Enhancement of chitosan-mediated gene delivery through combination with phiC31 integrase
    Ana Vanessa Oliveira, Gabriela A. Silva, Daniel C. Chung · 2015 · Acta Biomaterialia
97. Plant MicroRNAs
    Rebecca Schwab, Ossowski, Stephan, Warthmann, Norman, Weigel, Detlef · 2009 · Methods in molecular biology
98. Rewiring Cas9 to Target New PAM Sequences
    Virginijus Šikšnys, Giedrius Gasiūnas · 2016 · Molecular Cell
99. Stepping toward therapeutic CRISPR
    Keith T. Gagnon, David R. Corey · 2015 · Proceedings of the National Academy of Sciences